A Feily, M R Namazi. Show Affiliations »
Abstract
Entities: Chemical
Mesh: See more » 3',5'-Cyclic-AMP Phosphodiesterases/antagonists & inhibitorsAnimalsAntioxidants/pharmacologyAntioxidants/therapeutic useCyclic AMP/metabolismDose-Response Relationship, DrugGlycogen Synthase Kinase 3/metabolismHumansMiceSilymarin/pharmacologySilymarin/therapeutic useVitiligo/drug therapy
Substances: See more » AntioxidantsSilymarinCyclic AMPGlycogen Synthase Kinase 33',5'-Cyclic-AMP Phosphodiesterases
Year: 2011 PMID: 21726498 DOI: 10.5414/cp201557
Source DB: PubMed Journal: Int J Clin Pharmacol Ther ISSN: 0946-1965 Impact factor: 1.366